2072-6732

Journal Infectology

SPRIDA

View prefix report (10.22625)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 749 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact749 DOIs
2

Add abstracts to 210 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact210 DOIs
3

Deposit reference lists for 172 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact172 DOIs

DOIs for this ISSN

Showing the top 5 of 716 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 THE ROLE AND PLACE OF LOGISTIC REGRESSION AND ROC ANALYSIS I… (10.22625/2072-6732-2016-8-4-36-45)
Abstract References ORCID License
161.28 40
2 The prevalence of the hepatitis C virus among the conditiona… (10.22625/2072-6732-2017-9-2-56-64)
Abstract References ORCID License
123.04 16
3 COMPLICATIONS OF CHICKENPOX (LITERATURE REVIEW) (10.22625/2072-6732-2017-9-3-117-128)
Abstract References ORCID License
114.61 13
4 NONPOLIO ENTEROVIRUSES WHICH CAUSED THE RISE OF ENTEROVIRUS… (10.22625/2072-6732-2017-9-3-98-108)
Abstract References ORCID License
107.92 11
5 Comparative clinical and economic evaluation of two alternat… (10.22625/2072-6732-2018-10-2-110-116)
Abstract References ORCID License
107.92 11
6 DEFEAT OF THE CARDIOVASCULAR SYSTEM IN VIRAL INFECTIONS (10.22625/2072-6732-2017-9-4-14-23)
Abstract References ORCID License
95.42 8
7 NOROVIRUS INFECTION (SYSTEMATIC REVIEW) (10.22625/2072-6732-2018-10-1-5-14)
Abstract References ORCID License
95.42 8
8 CHRONIC VIRAL HEPATITIS, TUBERCULOSIS, AND HIV AS COMORBIDIT… (10.22625/2072-6732-2017-9-4-126-132)
Abstract References ORCID License
90.31 7
9 Efficacy and safety of novel russian non-nucleoside reverse… (10.22625/2072-6732-2018-10-2-76-82)
Abstract References ORCID License
90.31 7
10 PROBLEMATIC ISSUES OF COMBINED INTESTINAL INFECTIONS (10.22625/2072-6732-2016-8-4-11-19)
Abstract References ORCID License
84.51 6
11 The prevalence of serological markers of viral hepatitis amo… (10.22625/2072-6732-2017-9-2-80-85)
Abstract References ORCID License
84.51 6
12 TB SCREENING IN HIV- INFECTED PRISONERS, RELEASED PRISONERS… (10.22625/2072-6732-2017-9-1-76-84)
Abstract References ORCID License
77.82 5
13 The averted costs due to influenza vaccination with trivalen… (10.22625/2072-6732-2017-9-2-17-22)
Abstract References ORCID License
77.82 5
14 Vaccine prevention of rotavirus infection: Social significan… (10.22625/2072-6732-2017-9-2-65-71)
Abstract References ORCID License
77.82 5
15 Dynamics and structure of mortality of patients with HIV inf… (10.22625/2072-6732-2017-9-2-86-92)
Abstract References ORCID License
77.82 5
16 CAUSES OF DEATH IN HIV-INFECTED PATIENTS IN A LARGE TUBERCUL… (10.22625/2072-6732-2017-9-3-25-31)
Abstract References ORCID License
77.82 5
17 CONCOMITANT DISEASES AND RISK FACTORS FOR THEIR DEVELOPMENT… (10.22625/2072-6732-2017-9-3-40-45)
Abstract References ORCID License
77.82 5
18 Issues of pathology of a new coronavirus infection CoVID-19 (10.22625/2072-6732-2020-12-2-5-11)
Abstract ORCID
76.57 33
19 HEART DISEASE IN CHILDREN WITH RESPIRATORY INFECTIONS (10.22625/2072-6732-2016-8-4-20-25)
Abstract References ORCID License
69.90 4
20 THE EFFECT OF DISORDER OF FORMATION OF THE INTESTINAL MICROB… (10.22625/2072-6732-2017-9-1-55-61)
Abstract References ORCID License
69.90 4
21 BIOCHEMICAL SUBSTANTIATION OF COMBINED THERAPY APPLICATION I… (10.22625/2072-6732-2017-9-3-32-39)
Abstract References ORCID License
69.90 4
22 РОЛЬ ТРОМБОЦИТОВ В ПАТОГЕНЕЗЕ БАКТЕРИАЛЬНЫХ ИНФЕКЦИЙ (10.22625/2072-6732-2017-9-4-5-13)
Abstract References ORCID License
69.90 4
23 МORBIDITY OF INFLUENZA AND ACUTE VIRAL INFECTION IN YAKUTIA… (10.22625/2072-6732-2018-10-1-103-112)
Abstract References ORCID License
69.90 4
24 A TYPICAL PATIENT WITH HIV TODAY: COMPREHENSIVE CHARACTERIZA… (10.22625/2072-6732-2018-10-1-62-69)
Abstract References ORCID License
69.90 4
25 ANALYSIS OF FACTORS ASSOCIATED WITH PUBLIC CONFIDENCE IN VAC… (10.22625/2072-6732-2018-10-1-80-88)
Abstract References ORCID License
69.90 4
26 Fecal calprotectin in the differential diagnosis of acute in… (10.22625/2072-6732-2018-10-2-117-122)
Abstract References ORCID License
69.90 4
27 Vaccinal prevention of infectious diseases in adults (10.22625/2072-6732-2018-10-2-5-16)
Abstract References ORCID License
69.90 4
28 Anthrax does not forgive mistakes: the information assessmen… (10.22625/2072-6732-2017-9-2-5-27)
Abstract References ORCID License
60.21 3
29 INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE… (10.22625/2072-6732-2017-9-3-67-74)
Abstract References ORCID License
60.21 3
30 LETHAL OUTCOMES IN INFLUENZA: CLINIC-PATHOLOGICAL APPROACH T… (10.22625/2072-6732-2017-9-4-53-58)
Abstract References ORCID License
60.21 3
31 EFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGY… (10.22625/2072-6732-2017-9-4-59-68)
Abstract References ORCID License
60.21 3
32 COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE P… (10.22625/2072-6732-2017-9-4-93-101)
Abstract References ORCID License
60.21 3
33 ASSESMENT OF ADHERENCE TO ARVT IN HIV-POSITIVE PATIENTS WITH… (10.22625/2072-6732-2018-10-1-29-35)
Abstract References ORCID License
60.21 3
34 AGE DIFFERENCES OF THE EРSHTEIN – BARR VIRUS INFECTIOUS MONO… (10.22625/2072-6732-2018-10-1-36-41)
Abstract References ORCID License
60.21 3
35 RESPIRATORY SYNCYTIAL VIRUS INFECTION OF LOWER RESPIRATORY T… (10.22625/2072-6732-2018-10-1-55-61)
Abstract References ORCID License
60.21 3
36 ANTIRETROVIRAL ROLE IN TUBERCULOSIS PREVENTION AMONG PEOPLE… (10.22625/2072-6732-2018-10-1-89-95)
Abstract References ORCID License
60.21 3
37 Pertussis vaccination: problems, possible solutions (10.22625/2072-6732-2020-12-2-50-57)
Abstract ORCID
57.31 13
38 Current epidemiological characteristics of pertussis in the… (10.22625/2072-6732-2020-12-2-142-150)
Abstract ORCID
50.00 9
39 CLINICAL AND EPIDEMIOLOGICAL FEATURES OF THE BRUCELLOSIS IN… (10.22625/2072-6732-2016-8-4-26-30)
Abstract References ORCID License
47.71 2
40 EPIDEMIOLOGICAL SITUATION ON HIV INFECTION IN THE REPUBLIC… (10.22625/2072-6732-2016-8-4-31-35)
Abstract References ORCID License
47.71 2
41 ADRENOCORTICOTROPIN HORMONE AND CORTISOL DYNAMIC VARIATION… (10.22625/2072-6732-2016-8-4-50-57)
Abstract References ORCID License
47.71 2
42 CLINICAL AND LABORATORY CHARACTERISTICS OF CHRONIC HEPATITI… (10.22625/2072-6732-2016-8-4-72-78)
Abstract References ORCID License
47.71 2
43 THE ORGANIZATION OF HOSPITAL CARE DURING THE EPIDEMIC OF INF… (10.22625/2072-6732-2016-8-4-79-87)
Abstract References ORCID License
47.71 2
44 GENE-CELL THERAPY OF HIV AND HEMATOLOGICAL MALIGNANCES BASED… (10.22625/2072-6732-2017-9-1-31-39)
Abstract References ORCID License
47.71 2
45 GENETICS OF SUSCEPTIBILITY TO INFECTIOUS DISEASES (10.22625/2072-6732-2017-9-1-40-46)
Abstract References ORCID License
47.71 2
46 EPIDEMIOLOGICAL, CLINICAL AND LABORATORY FEATURES OF IMPORTE… (10.22625/2072-6732-2017-9-1-91-99)
Abstract References ORCID License
47.71 2
47 THE MAIN DIRECTIONS OF ART IN HIV-INFECTED CITIZENS OF THE L… (10.22625/2072-6732-2017-9-3-109-116)
Abstract References ORCID License
47.71 2
48 ACUTE NEUROINFECTIONS AND SYMPTOMATIC EPILEPSY IN CHILDREN:… (10.22625/2072-6732-2017-9-3-5-13)
Abstract References ORCID License
47.71 2
49 HOMOLOGY BETWEEN SEGMENTS OF HUMAN HEMOSTATIC PROTEINS AND P… (10.22625/2072-6732-2017-9-3-81-91)
Abstract References ORCID License
47.71 2
50 TOXIC EPIDERMAL NECROLYSIS (LYELL’S SYNDROME) (10.22625/2072-6732-2017-9-4-144-152)
Abstract References ORCID License
47.71 2